AMPD2 Gene SPG63 Genetic Test sale cost 4400 AED
ZFYVE27 Gene SPG33 Genetic Test sale cost 4400 AED ZFYVE27 Gene SPG33 Genetic Test Cost 5,600 د.إ Original price was: 5,600 د.إ.4,400 د.إCurrent price is: 4,400 د.إ.
WASHC5 Gene SPG8 Genetic Test sale cost 4400 AED WASHC5 Gene SPG8 Genetic Test Cost 5,600 د.إ Original price was: 5,600 د.إ.4,400 د.إCurrent price is: 4,400 د.إ.
Sale!

AMPD2 Gene SPG63 Genetic Test Cost

Original price was: 5,600 د.إ.Current price is: 4,400 د.إ.

-21%

The AMPD2 Gene SPG63 Genetic Test is a specialized diagnostic procedure designed to identify mutations in the AMPD2 gene, which are associated with Spastic Paraplegia 63 (SPG63). SPG63 is a form of hereditary spastic paraplegia, a group of genetic disorders characterized by progressive stiffness and weakness of the legs. The AMPD2 gene plays a critical role in the development and maintenance of the nervous system, and mutations in this gene can lead to various neurological symptoms, including difficulties with walking and coordination.

This genetic test involves analyzing the patient’s DNA to detect any abnormalities in the AMPD2 gene that could lead to SPG63. It is a crucial tool for healthcare providers in diagnosing this rare condition, enabling them to offer appropriate management and treatment options for affected individuals. Early diagnosis can also help in understanding the progression of the disease and in providing genetic counseling to families.

The test is available at DNA Labs UAE, a leading facility in genetic testing and analysis. The cost of the AMPD2 Gene SPG63 Genetic Test is 4400 AED. DNA Labs UAE employs advanced genetic testing technologies and methodologies to ensure accurate and reliable results, offering patients and their families critical insights into their genetic health.

Home  Sample collection service available

  • 100% accuaret Test Results
  • Ranked as Most trusted Genetic DNA Lab
  • This test is not intended for medical diagnosis or treatment
Guaranteed Safe Checkout

AMPD2 Gene SPG63 Genetic Test

Test Name: AMPD2 Gene SPG63 Genetic Test

Components: NGS Technology

Price: 4400.0 AED

Sample Condition: Blood or Extracted DNA or One drop Blood on FTA Card

Report Delivery: 3 to 4 Weeks

Test Type: Neurological Disorders

Doctor: Neurologist

Test Department: Genetics

Pre Test Information: Clinical History of Patient who is going for AMPD2 Gene SPG63 NGS Genetic DNA Test. A Genetic Counselling session to draw a pedigree chart of family members affected with AMPD2 Gene SPG63.

Test Details:

The AMPD2 gene is associated with a condition called spastic paraplegia 63 (SPG63), which is a rare hereditary disorder characterized by progressive stiffness and weakness of the legs (spastic paraplegia).

NGS (Next-Generation Sequencing) genetic testing is a method used to analyze the DNA sequence of an individual’s genes. It is a high-throughput technology that allows for the simultaneous sequencing of multiple genes or the entire genome. NGS can be used to identify mutations or variations in the AMPD2 gene that may be responsible for SPG63.

NGS genetic testing for SPG63 would involve obtaining a DNA sample, typically through a blood or saliva sample, from the individual suspected of having the condition. The DNA would then be sequenced using NGS technology to analyze the AMPD2 gene and identify any mutations or variations that may be present.

This genetic test can help confirm a diagnosis of SPG63 and provide valuable information for genetic counseling, prognosis, and potential treatment options. It is typically ordered by a healthcare professional with expertise in genetic testing and rare genetic disorders.

Test Name AMPD2 Gene SPG63 Genetic Test
Components
Price 4400.0 AED
Sample Condition Blood or Extracted DNA or One drop Blood on FTA Card o
Report Delivery 3 to 4 Weeks
Method NGS Technology
Test type Neurological Disorders
Doctor Neurologist
Test Department: Genetics
Pre Test Information Clinical History of Patient who is going for AMPD2 Gene SPG63 NGS Genetic DNA Test A Genetic Counselling session to draw a pedigree chart of family members affected with AMPD2 Gene SPG63
Test Details

The AMPD2 gene is associated with a condition called spastic paraplegia 63 (SPG63), which is a rare hereditary disorder characterized by progressive stiffness and weakness of the legs (spastic paraplegia).

NGS (Next-Generation Sequencing) genetic testing is a method used to analyze the DNA sequence of an individual’s genes. It is a high-throughput technology that allows for the simultaneous sequencing of multiple genes or the entire genome. NGS can be used to identify mutations or variations in the AMPD2 gene that may be responsible for SPG63.

NGS genetic testing for SPG63 would involve obtaining a DNA sample, typically through a blood or saliva sample, from the individual suspected of having the condition. The DNA would then be sequenced using NGS technology to analyze the AMPD2 gene and identify any mutations or variations that may be present.

This genetic test can help confirm a diagnosis of SPG63 and provide valuable information for genetic counseling, prognosis, and potential treatment options. It is typically ordered by a healthcare professional with expertise in genetic testing and rare genetic disorders.

SKU: TEST-2028 Category:

Related products